Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biotron ( (AU:BIT) ) has provided an update.
Biotron Limited has announced the dispatch of its prospectus and the opening of a non-renounceable entitlement offer, which was initially announced on October 15, 2025. The offer includes the issuance of attaching options and is aimed at eligible shareholders, with the rights issue set to close on December 12, 2025. This move is expected to provide investors with an opportunity to gain exposure to the company’s equities, potentially impacting its market positioning and stakeholder interests.
More about Biotron
Biotron Limited is a micro-cap biotechnology company listed on the Australian Securities Exchange (ASX). The company focuses on developing innovative biotechnology solutions and products.
Technical Sentiment Signal: Sell
Current Market Cap: A$3.82M
See more insights into BIT stock on TipRanks’ Stock Analysis page.